#CRAVAT Report
#Created at Wednesday 04/07/2021 13:37:08
#Report level: variant
#
Variant Annotation																PharmGKB			
UID	Chrom	Position	Ref Base	Alt Base	Note	Coding	Gene	Transcript	Sequence Ontology	cDNA change	Protein Change	All Mappings	Sample Count	Samples	Tags	ID	Chemicals	Phenotype Category	All Annotations
1	chr6_GL000250v2_alt	1096643	A	G			HLA-G	ENST00000615464.4	3_prime_UTR_variant	c.*292A>G		ENST00000612360.4:HLA-G::3_prime_UTR_variant::c.*292A>G; ENST00000615098.4:HLA-G::3_prime_UTR_variant::c.*292A>G; ENST00000615464.4:HLA-G::3_prime_UTR_variant::c.*292A>G; ENST00000618039.4:HLA-G::NMD_transcript_variant,3_prime_UTR_variant::c.*340A>G; ENST00000618812.1:HLA-G::3_prime_UTR_variant::c.*282A>G; ENST00000622601.4:HLA-G:P17693:3_prime_UTR_variant::c.*292A>G	1	s0					
2	chr22	19965038	G	A			COMT	ENST00000361682.11	intron_variant	c.615+739G>A		ENST00000207636.9:COMT::intron_variant,NMD_transcript_variant::c.*73+739G>A; ENST00000361682.11:COMT:P21964:intron_variant::c.615+739G>A; ENST00000403184.5:COMT::3_prime_UTR_variant::c.*646G>A; ENST00000403710.5:COMT:P21964:intron_variant::c.615+739G>A; ENST00000406520.7:COMT:P21964:intron_variant::c.615+739G>A; ENST00000407537.5:COMT:P21964:intron_variant::c.615+739G>A; ENST00000449653.5:COMT:P21964:intron_variant::c.465+739G>A; ENST00000493893.1:COMT::2kb_downstream_variant,processed_transcript::; ENST00000585066.1:MIR4761::2kb_downstream_variant,miRNA::	1	s0		PA166178598	morphine	Dosage,Efficacy	[[[["morphine", "https://www.pharmgkb.org/chemical/PA450550"]], "Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.", "Dosage,Efficacy", "no", "26902643", "Haplotype of the six COMT variants studied in the paper was also not significantly associated with morphine dose requirements."]]
3	chr3	49682366	G	T		Yes	APEH	ENST00000296456.10	missense_variant	c.1622G>T	p.Thr541Met	ENST00000296456.10:APEH:P13798:missense_variant:p.Thr541Met:c.1622G>T; ENST00000438011.5:APEH::missense_variant:p.Thr541Met:c.1622G>T; ENST00000449682.2:MST1::2kb_downstream_variant::c.*1662C>A	1	s0					
4	chr3	49682366	G	A		Yes	APEH	ENST00000296456.10	missense_variant	c.1622G>A	p.Thr541Lys	ENST00000296456.10:APEH:P13798:missense_variant:p.Thr541Lys:c.1622G>A; ENST00000438011.5:APEH::missense_variant:p.Thr541Lys:c.1622G>A; ENST00000449682.2:MST1::2kb_downstream_variant::c.*1662C>T	1	s0					
5	chr10	113049143	G	A			TCF7L2	ENST00000627217.3	intron_variant	c.552+9017G>A		ENST00000352065.10:TCF7L2:Q9NQB0:intron_variant::c.483+9017G>A; ENST00000355717.9:TCF7L2:Q9NQB0:intron_variant::c.483+9017G>A; ENST00000355995.8:TCF7L2:Q9NQB0:intron_variant::c.552+9017G>A; ENST00000369395.6:TCF7L2::intron_variant::c.483+9017G>A; ENST00000369397.8:TCF7L2:Q9NQB0:intron_variant::c.483+9017G>A; ENST00000534894.5:TCF7L2::intron_variant::c.382-92041G>A; ENST00000536810.5:TCF7L2::intron_variant::c.483+9017G>A; ENST00000538897.5:TCF7L2:Q9NQB0:intron_variant::c.552+9017G>A; ENST00000542695.5:TCF7L2::intron_variant::c.165+9017G>A; ENST00000543371.5:TCF7L2::intron_variant::c.552+9017G>A; ENST00000545257.6:TCF7L2::intron_variant::c.483+9017G>A; ENST00000627217.3:TCF7L2:Q9NQB0:intron_variant::c.552+9017G>A; ENST00000629706.2:TCF7L2::intron_variant::c.483+9017G>A	1	s0		PA166154148	sulfonamides, urea derivatives	Efficacy	[[[["sulfonamides, urea derivatives", "https://www.pharmgkb.org/chemical/PA10390"]], "Genotype TT is associated with decreased response to sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to genotype GG.", "Efficacy", "yes", "17519421", ""]]
6	chr6_GL000251v2_alt	4385247	C	T			BRD2	ENST00000442863.5	intron_variant	c.29+111C>T		ENST00000383108.6:BRD2:P25440:intron_variant::c.29+111C>T; ENST00000438194.6:BRD2:P25440:intron_variant::c.29+111C>T; ENST00000442863.5:BRD2:P25440:intron_variant::c.29+111C>T; ENST00000466744.1:BRD2::2kb_downstream_variant,processed_transcript::; ENST00000492172.5:BRD2::intron_variant,NMD_transcript_variant::c.29+111C>T; ENST00000493063.5:BRD2::intron_variant,NMD_transcript_variant::c.29+111C>T	1	s0					
7	chr9	9687487	C	G			PTPRD	ENST00000381196.8	intron_variant	c.-287+47046G>C		ENST00000381196.8:PTPRD:P23468:intron_variant::c.-287+47046G>C; ENST00000463477.5:PTPRD::intron_variant::c.-359+47046G>C	1	s0		PA166157776	trandolapril verapamil	Efficacy	[[[["trandolapril", "https://www.pharmgkb.org/chemical/PA451737"], ["verapamil", "https://www.pharmgkb.org/chemical/PA451868"]], "Allele T is associated with resistance to trandolapril and verapamil in people with Hypertension as compared to allele C.", "Efficacy", "yes", "26425837", "This was associated with resistant hypertension in whites and Hispanics in the international verapamil SR trandolapril study (meta-analysis P=3.2\u00d710-5)."]]
#CRAVAT Report
#Created at Wednesday 04/07/2021 13:37:08
#Report level: gene
#
Variant Annotation					
Gene	Note	Number of Coding Variants	Number of Noncoding Variants	Sequence Ontology	All Sequence Ontologies
HLA-G		0	1	3_prime_UTR_variant	NMD_transcript_variant(1),3_prime_UTR_variant(1)
COMT		0	1	intron_variant	intron_variant(1),NMD_transcript_variant(1),processed_transcript(1),3_prime_UTR_variant(1)
APEH		2	0	missense_variant	missense_variant(2)
TCF7L2		0	1	intron_variant	intron_variant(1)
BRD2		0	1	intron_variant	intron_variant(1),NMD_transcript_variant(1),processed_transcript(1)
PTPRD		0	1	intron_variant	intron_variant(1)
#CRAVAT Report
#Created at Wednesday 04/07/2021 13:37:08
#Report level: sample
#
Variant Annotation	
UID	Sample
1	s0
2	s0
3	s0
4	s0
5	s0
6	s0
7	s0
#CRAVAT Report
#Created at Wednesday 04/07/2021 13:37:08
#Report level: mapping
#
Variant Annotation			
Original Line	User Tags	UID	Input File Number
1		1	0
2		2	0
3		3	0
4		4	0
5		5	0
6		6	0
7		7	0
